Inhibition of HBV replication by delivering the dual-gene expression vector pHsa-miR16-siRNA in HepG2.2.15 cells

Abstract

This study aimed to construct the dual-gene expression vector pHsa-miR16-siRNA which can express human miR-16 and HBV X siRNA, and examine its regulatory effect on HBV gene expression in the HepG2.2.15 cell line. The expression vectors siR-1583 and pHsa-miR16-siRNA were designed and constructed. HepG2.2.15 cells were transfected with the empty vector, siR-1583, pmiR-16 and pHsa-miR16-siRNA, respectively. ELISA was performed to measure the expression of HBsAg and HBeAg in the culture supernatant 48 and72 h post transfection. Fluorescence quantitative PCR was used to measure the HBV mRNA degradation efficiency and HBV DNA copy number. The results showed that the expression of HBV genes was significantly inhibited in HepG2.2.15 cells transfected with siR-1583, pmiR-16 and pHsa-miR16-siRNA, respectively, when compared with that in cells transfected with the empty vectors, with the inhibitory effect of pHsa-miR16-siRNA being the most significant. ELISA showed that the inhibitory rates of HBsAg and HBeAg in pHsa-miR16-siRNA transfected cells were correspondingly 87.3% and 85.0% at 48 h, and 88.6% and 86.5% at 72 h post transfection (P<0.01 vs. control group). RT-PCR showed that the level of HBV mRNA decreased by 80.2% (t=–99.22, P<0.01), the genomic HBV DNA by 92.8% (t=–73.06, P<0.01), and the supernatant of HBV DNA copy number by 89.8% (t=–47.13, P<0.01) in pHsa-miR16-siRNA transfected group. It was suggested that the dual-gene expression vector pHsa-miR16-siRNA can inhibit the replication of HBV more efficiently than a single-gene expression vector.

Keywords

dual expression vector / HBV DNA / HBV mRNA / gene expression

References

[1] WHO 2013 Hepatitis B Virus Fact Sheet No. 204 (Updated July 2013)

[2] ZoulimF, DurantelD. Antiviral therapies and prospects for a cure of chronic hepatitis B. Csh Perspect Med, 2015, 5(4): a021501-a021501

[3] GishR, JiaJD, LocarniniS, et al. . Selection of chronic hepatitis B therapy with high barrier to resistance. Lancet Infect Dis, 2012, 12(4): 341-353 PMID: 22326017

[4] BouchardMJ, PuroRJ, SchneiderRJ, et al. . Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication. J Virol, 2003, 77(14): 7713-7719 PMID: 12829810 PMCID: 161925

[5] ZhangXD, WangY, YeLH. Hepatitis B virus X protein accelerates the development of hepatoma. Cancer Biol Med, 2014, 11(3): 182-190 PMID: 25364579 PMCID: 4197427

[6] DengWY, LuMJ. The role of microRNAs in hepatocyte metabolism and hepatitis B virus replication. Virologica Sinica, 2016, 31(6): 472-479 PMID: 28063013 PMCID: 8193420

[7] ZhangXY, YuB, LvTT, et al. . Construction and identification of eukaryotic expression vector of miR-16. J Mol Biol, 2008, 5(1): 31-34

[8] MorrisseyDV, LockridgeJA, ShawL, et al. . Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol, 2005, 23(8): 1002-1007 PMID: 16041363

[9] WenWH, LiuJY, QinWJ, et al. . Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA delivery. Hepatology, 2007, 46(1): 84-94 PMID: 17596868

[10] BrummelkampTR, BernardsR, AgamiR. A system for stable expression of short interfering RNAs in mammalian cells. Science, 2002, 296(5567): 550-553 PMID: 11910072

[11] AcharyaR, SahaS, RayS, et al. . siRNA-nanoparticle conjugate in gene silencing: A future cure to deadly diseases. Mat SciEng C-Mater, 2017, 76: 1378-1400

[12] BarikS. Silence of the transcripts: RNA interference in medicine. J Mol Med, 2005, 83(10): 764-773 PMID: 16028076

[13] KlemmV, MitchellJ, CortezjugoC, et al. . Achieving HIV-1 control through RNA-directed gene regulation. Genes, 2016, 7(12): 119 PMCID: 5192495

[14] HouZ, QuanJ. Hepatitis B virus X protein increases microRNA-21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B signaling pathway. Mol Med Rep, 2017, 15(5): 3285-3291 PMID: 28339072

[15] CarmonaS, ElyA, CrowtherC, et al. . Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs. Mol Ther, 2006, 13(2): 411-421 PMID: 16337206

[16] WuG, YuF, XiaoZ, et al. . Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Brit J Cancer, 2011, 105(1): 146-153 PMID: 21629246 PMCID: 3137408

[17] KhokharA, NooraliS, SherazM, et al. . Computational analysis to predict functional role of hsa-miR-3065-3p as an antiviral therapeutic agent for treatment of triple infections: HCV, HIV-1, and HBV. Libyan J Med, 2012, 7(1): 19774 PMID: 23289041